Safety testing programs for gene therapy viral vectors.
作者信息
Ostrove J M
机构信息
Microbiological Associates, Inc., Rockville, Maryland 20850, USA.
出版信息
Cancer Gene Ther. 1994 Jun;1(2):125-31.
PMID:7621244
Abstract
摘要
相似文献
1
Safety testing programs for gene therapy viral vectors.基因治疗病毒载体的安全性测试程序。
Cancer Gene Ther. 1994 Jun;1(2):125-31.
2
Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.敦促对腺病毒载体进行更严格监测……并提议报告所有“不良事件”。
Nature. 1999 Dec 16;402(6763):707. doi: 10.1038/45321.
3
Target and non-target effects of retrovirus vectors used for gene therapy and vaccination.
Dev Biol Stand. 1995;84:59-74.
4
A tumultuous year for gene therapy.基因治疗的动荡之年。
Mol Ther. 2000 Nov;2(5):415-6. doi: 10.1006/mthe.2000.0213.
5
Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.载体上清液中包装细胞系DNA污染：对实验室和临床研究的影响。
Virology. 2001 Mar 30;282(1):186-97. doi: 10.1006/viro.2001.0826.
6
Biotechnology industry responds to gene therapy death.生物技术行业对基因治疗死亡事件作出回应。
Nat Med. 2000 Feb;6(2):118. doi: 10.1038/72181.
7
Looking into the safety of AAV vectors.探究腺相关病毒载体的安全性。
Nature. 2003 Jul 17;424(6946):251. doi: 10.1038/424251b.
8
Infection control for gene therapy: a busy physician's primer.基因治疗的感染控制：忙碌医生的入门指南。
Clin Infect Dis. 2002 Sep 1;35(5):597-605. doi: 10.1086/342194. Epub 2002 Aug 7.
9
Gene therapy. Second child in French trial is found to have leukemia.基因疗法。法国试验中的第二名儿童被发现患有白血病。
Science. 2003 Jan 17;299(5605):320. doi: 10.1126/science.299.5605.320.
10
Vector characterization methods for quality control testing of recombinant adeno-associated viruses.用于重组腺相关病毒质量控制测试的载体表征方法
Methods Mol Biol. 2011;737:247-78. doi: 10.1007/978-1-61779-095-9_11.
Zotero 插件